toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Records Links
Author Sharkey, K.M.; Carskadon, M.A.; Figueiro, M.G.; Zhu, Y.; Rea, M.S. url  doi
openurl 
  Title Effects of an advanced sleep schedule and morning short wavelength light exposure on circadian phase in young adults with late sleep schedules Type Journal Article
  Year 2011 Publication Sleep Medicine Abbreviated Journal Sleep Med  
  Volume 12 Issue 7 Pages 685-692  
  Keywords Affect/physiology/radiation effects; Circadian Rhythm/*physiology/*radiation effects; Color; Dose-Response Relationship, Radiation; Female; Humans; *Light; Male; Melatonin/metabolism; Photoperiod; Phototherapy/*methods; Saliva/metabolism; Sleep/physiology/radiation effects; Sleep Disorders, Circadian Rhythm/prevention & control/*therapy; Stress, Psychological/prevention & control/therapy; Treatment Outcome; Young Adult; blue light  
  Abstract OBJECTIVE: We examined the effects of an advanced sleep/wake schedule and morning short wavelength (blue) light in 25 adults (mean age+/-SD=21.8+/-3 years; 13 women) with late sleep schedules and subclinical features of delayed sleep phase disorder (DSPD). METHODS: After a baseline week, participants kept individualized, fixed, advanced 7.5-h sleep schedules for 6days. Participants were randomly assigned to groups to receive “blue” (470nm, approximately 225lux, n=12) or “dim” (<1lux, n=13) light for 1h after waking each day. Head-worn “Daysimeters” measured light exposure; actigraphs and sleep diaries confirmed schedule compliance. Salivary dim light melatonin onset (DLMO), self-reported sleep, and mood were examined with 2x2 ANOVA. RESULTS: After 6days, both groups showed significant circadian phase advances, but morning blue light was not associated with larger phase shifts than dim-light exposure. The average DLMO advances (mean+/-SD) were 1.5+/-1.1h in the dim light group and 1.4+/-0.7h in the blue light group. CONCLUSIONS: Adherence to a fixed advanced sleep/wake schedule resulted in significant circadian phase shifts in young adults with subclinical DSPD with or without morning blue light exposure. Light/dark exposures associated with fixed early sleep schedules are sufficient to advance circadian phase in young adults.  
  Address Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Alpert Medical School of Brown University, Box G-RIH, Providence, RI 02912, USA. katherine_sharkey@brown.edu  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1389-9457 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:21704557; PMCID:PMC3145013 Approved no  
  Call Number IDA @ john @ Serial 303  
Permanent link to this record
 

 
Author Skene, D.J.; Arendt, J. url  doi
openurl 
  Title Circadian rhythm sleep disorders in the blind and their treatment with melatonin Type Journal Article
  Year 2007 Publication Sleep Medicine Abbreviated Journal Sleep Med  
  Volume 8 Issue 6 Pages 651-655  
  Keywords Human Health; Blindness/*complications; Chronotherapy; Circadian Rhythm/drug effects; Humans; Melatonin/*administration & dosage; Sleep/drug effects; Sleep Disorders, Circadian Rhythm/*drug therapy/*etiology; Treatment Outcome  
  Abstract People who are blind, in addition to having to cope with partial or no sight, have an added handicap; the transmission of ocular light from the retina to their circadian clock is impaired. At its worse, for example in people with both eyes enucleated, this lesion results in desynchronisation of the biological clock (located in the hypothalamic suprachiasmatic nuclei) from the 24h day/night environment. While in a desynchronised state, symptoms akin to jet lag are experienced (e.g., daytime sleepiness, poor night sleep, reduced alertness and performance during waking). This is a lifelong condition. Daily administration of exogenous melatonin is the current treatment of choice for this so-called “non-24h sleep/wake disorder”. Melatonin has been shown to correct the underlying circadian rhythm abnormality as well as improve sleep and reduce daytime napping. The effectiveness of melatonin therapy depends upon its time of administration relative to the timing of the person's circadian clock. If practicable, assessment of an individual's circadian phase (by measurement of the endogenous melatonin rhythm in plasma, saliva or urine) is recommended prior to commencing treatment to optimise melatonin's effectiveness.  
  Address Centre for Chronobiology, School of Biomedical and Molecular Sciences, University of Surrey, Guildford GU2 7XH, UK. d.skene@surrey.ac.uk  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1389-9457 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:17420154 Approved no  
  Call Number LoNNe @ kagoburian @ Serial 811  
Permanent link to this record
 

 
Author Srinivasan, V.; Smits, M.; Spence, W.; Lowe, A.D.; Kayumov, L.; Pandi-Perumal, S.R.; Parry, B.; Cardinali, D.P. url  doi
openurl 
  Title Melatonin in mood disorders Type Journal Article
  Year 2006 Publication The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry Abbreviated Journal World J Biol Psychiatry  
  Volume 7 Issue 3 Pages 138-151  
  Keywords Human Health; Antidepressive Agents/therapeutic use; Biological Markers/blood; Bipolar Disorder/diagnosis/drug therapy/*physiopathology; Circadian Rhythm/drug effects/physiology; Depressive Disorder/diagnosis/drug therapy/*physiopathology; Depressive Disorder, Major/diagnosis/drug therapy/physiopathology; Humans; Melatonin/*blood/therapeutic use; Phototherapy; Seasonal Affective Disorder/diagnosis/physiopathology; Sleep Disorders, Circadian Rhythm/diagnosis/drug therapy/physiopathology; Treatment Outcome  
  Abstract The cyclic nature of depressive illness, the diurnal variations in its symptomatology and the existence of disturbed sleep-wake and core body temperature rhythms, all suggest that dysfunction of the circadian time keeping system may underlie the pathophysiology of depression. As a rhythm-regulating factor, the study of melatonin in various depressive illnesses has gained attention. Melatonin can be both a 'state marker' and a 'trait marker' of mood disorders. Measurement of melatonin either in saliva or plasma, or of its main metabolite 6-sulfatoxymelatonin in urine, have documented significant alterations in melatonin secretion in depressive patients during the acute phase of illness. Not only the levels but also the timing of melatonin secretion is altered in bipolar affective disorder and in patients with seasonal affective disorder (SAD). A phase delay of melatonin secretion takes place in SAD, as well as changes in the onset, duration and offset of melatonin secretion. Bright light treatment, that suppresses melatonin production, is effective in treating bipolar affective disorder and SAD, winter type. This review discusses the role of melatonin in the pathophysiology of bipolar disorder and SAD.  
  Address Department of Physiology, School of Medical Sciences, University Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1562-2975 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:16861139 Approved no  
  Call Number LoNNe @ kagoburian @ Serial 816  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: